Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
NCT02762474
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
nab-paclitaxel group
Sponsor
Tianjin Medical University Cancer Institute and Hospital